Significance of tyrosine kinase activity on malign transformation of ovarian tumors: A comparison between EGF-R and TGF-α

Acta Histochemica

Volumn 110, Issue 3, 2008, Pages 256-263

  Zeren, Tamer ^a   Inan, Sevinc ^a   Seda Vatansever, H ^a   Ekerbicer, Nuran ^a   Sayhan, Sevil ^b  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b Agean Maternity Hospital   (Turkey)

Author keywords

EGF receptors; Immunoreactivity; Ovarian tumor; TGF ; Tyrosine kinase

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; TRANSFORMING GROWTH FACTOR ALPHA;

ADULT; ARTICLE; CELL SURFACE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALIGNANT TRANSFORMATION; OVARY ADENOCARCINOMA; OVARY CANCER; OVARY TUMOR; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; STAINING; TISSUE FIXATION;

EID: 43049145541     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2007.08.007     Document Type: Article

References (37)

1. A. Abdollahi B.N. Gruver C. Patriotis T.C. Hamilton Identification of epidermal growth factor-responsive genes in normal rat ovarian surface epithelial cells Biochem Biophys Res Commun 307 2003 188 197
2. J.M. Bartlett S.P. Langdon B.J. Simpson M. Stewart D. Katsaros P. Sismondi The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer Br J Cancer 73 1996 301 306
3. J. Baselga J. Mendelsohn The epidermal growth factor receptor as a target for therapy in breast carcinoma Breast Cancer Res Tr 29 1994 127 138
4. R.C. Bast Jr I. Jacobs A. Berchuck Malignant transformation of ovarian epithelium J Natl Cancer Inst 84 1992 556 558
5. M.A. Broome T. Hunter Requirement for c-Src catalytic activity and the SH3 domain in platelet-derived growth factor BB and epidermal growth factor mitogenic signaling J Biol Chem 271 1996 16798 16806
6. G. Carpenter S. Cohen Epidermal growth factor J Biol Chem 265 1990 7709 7712
7. C.H. Chien C.C. Huang Y.H. Lin J. Shen S.N. Chow Detection of serum transforming growth factor-alpha in patients of primary epithelial ovarian cancers by enzyme immunoassay Gynecol Oncol 66 1997 405 410
8. J.S. de Jong P.J. van Diest P. van d Valk J.P. Baak Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: correlations with proliferation and angiogenesis J Pathol 184 1998 53 57
9. J.E. de Larco G.J. Todaro Growth factors from murine sarcoma virus-transformed cells Proc Natl Acad Sci USA 75 1978 4001 4005
10. R. Derynck D.V. Goeddel A. Ullrich J.U. Gutterman R.D. Williams T.S. Bringman Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors Cancer Res 47 1987 707 712
11. P.J. DiSaia W.T. Creaseman Epithelial ovarian cancer P.J. DiSaia W.T. Creaseman Clinical oncology 1993 Mosby–Year Book St. Louis, MO 333 425
12. T.W. Grunt K. Puckmair K. Tomek B. Kainz A. Gaiger An EGF receptor inhibitor induces RAR-beta expression in breast and ovarian cancer cells Biochem Biophys Res Commun 329 2005 1253 1259
13. A. Jemal R. Siegel E. Ward T. Murray J. Xu M.J. Thun Cancer statistics, 2007 CA Cancer J Clin 57 2007 43 66
14. S.K. Jindal E. Ishii M. Letarte S. Vera K.J. Teerds J.H. Dorrington Regulation of transforming growth factor alpha gene expression in an ovarian surface epithelial cell line derived from a human carcinoma Biol Reprod 52 1995 1027 1037
15. J.P. Kallio P. Hirvikoski H. Helin P. Kellokumpu-Lehtinen T. Luukkaala T.L. Tammela Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma Br J Cancer 89 2003 1266 1269
16. K. Khazaie V. Schirrmacher R.B. Lichtner EGF receptor in neoplasia and metastasis Cancer Metast Rev 12 1993 255 274
17. A. Levitzki A. Gazit Tyrosine kinase inhibition: an approach to drug development Science 267 1995 1782 1788
18. J. Mendelsohn J. Baselga The EGF receptor family as targets for cancer therapy Oncogene 19 2000 6550 6565
19. J. Mendelsohn J. Baselga Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer J Clin Oncol 21 2003 2787 2799
20. K. Morishige H. Kurachi K. Amemiya H. Adachi M. Inoue A. Miyake Involvement of transforming growth factor alpha/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vitro Cancer Res 51 1991 5951 5955
21. K. Morishige H. Kurachi K. Amemiya Y. Fujita T. Yamamoto A. Miyake Evidence for the involvement of transforming growth factor alpha and epidermal growth factor receptor autocrine growth mechanism in primary human ovarian cancers in vitro Cancer Res 51 1991 5322 5328
22. J.S. Nielsen E. Jakobsen B. HØlund K. Bertelsen A. Jakobsen Prognostic significance of p53, Her-2, and EGFR overexpression in borderline and epithelial ovarian cancer Int J Gynecol Cancer 14 2004 1086 1096
23. O.J. Owens C. Stewart R.E. Leake Growth factors in ovarian cancer Br J Cancer 64 1991 1177 1181
24. O.J. Owens C. Stewart R.E. Leake A.M. McNicol A comparison of biochemical and immunohistochemical assessment of EGFR expression in ovarian cancer Anticancer Res 12 1992 1455 1458
25. V. Page M. Cote C. Rancourt M. Sullivan A. Piche BAG-1 p29 protein prevents drug-induced cell death in the presence of EGF and enhances resistance to anoikis in SKOV3 human ovarian cancer cells Biochem Biophys Res Commun 328 2005 874 884
26. S.L. Parker T. Tong S. Bolden P.A. Wingo Cancer statistics, 1997 CA Cancer J Clin 47 1997 5 27
27. M.S. Piver T.R. Baker M. Piedmonte A.M. Sandecki Epidemiology and etiology of ovarian cancer Semin Oncol 18 1991 177 185
28. S.A. Prigent N.R. Lemoine The type 1 (EGFR-related) family of growth factor receptors and their ligands Prog Growth Factor Res 4 1992 1 24
29. J. Schlessinger Ligand-induced, receptor-mediated dimerization and activation of EGF receptor Cell 110 2002 669 672
30. B.S. Skirnisdottir T. Seidal The growth factor receptors HER-2/neu and EGFR, their relationship, and their effects on the prognosis in early stage (FIGO I-II) epithelial ovarian carcinoma Int J Gynecol Pathol 11 2001 119 129
31. M.B. Sporn A.B. Roberts Peptide growth factors and their receptors 1991 Springer New York, NY
32. D.F. Stern Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases Breast Cancer Res 2 2000 176 183
33. K. Stromberg T.J. Collins IV A.W. Gordon C.L. Jackson G.R. Johnson Transforming growth factor-alpha acts as an autocrine growth factor in ovarian carcinoma cell lines Cancer Res 52 1992 341 347
34. F.M. Uckun R.K. Narla X. Jun T. Zeren T. Vencatachalam K.G. Waddick Cytotoxic activity of epidermal growth factor – genistein against breast cancer cells Clin Cancer Res 4 1998 901 912
35. F.M. Uckun R.K. Narla T. Zeren Y. Yanishevski D.E. Myers B. Waurzyniak In-vivo toxicity, pharmacokinetics, and anticancer activity of Genistein linked to recombinant human epidermal growth factor Clin Cancer Res 4 1998 1125 1134
36. J.D. Wright C.W. Reuter M.J. Weber An incomplete program of cellular tyrosine phosphorylations by kinase-defective epidermal growth factor receptors J Biol Chem 270 1995 12085 12093
37. T. Zeren N. Ekerbicer Tyrosine kinase inhibition and chemotherapy Sendrom 16 2004 45 48